Owner Alexion Pharmaceuticals, Inc.

Inventors Bowdish, Katherine S.; Kretz-Rommel, Anke

Agent Shelston IP

Pub. Number AU-B-2004299053

PCT Pub. Number WO2005/058244

Priority 60/529,517 15.12.03 US

Filing date 15 December 2004

Wipo publication date 30 June 2005

Acceptance publication date 6 January 2011

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/00 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/564 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for pre-existing immune complex or autoimmune disease

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer